The evolving place of vagus nerve stimulation therapy.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 12270961.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Approximately 40% of patients with epilepsy have seizures that do not adequately respond to medical therapy. Vagus nerve stimulation (VNS) therapy, approved 5 years ago by the Food and Drug Administration, offers a therapeutic option for patients with pharmacoresistant seizures. This supplement updates developments with VNS therapy since its approval and suggests future directions for this still-evolving treatment.
Medical subject headings
- Electric Stimulation Therapy
- Epilepsy, Generalized
- Vagus Nerve